Immunitybio, Inc. · NASDAQ:IBRX
Patrick Soon-Shiong reported a 66.30% stake in Immunitybio, Inc. (Schedule 13D/A)
Event Feb 23, 2026 · Filed Feb 25, 2026
Patrick Soon-Shiong reported a 66.30% stake in Immunitybio, Inc., 745,576,456 shares, with active intent on Feb 23, 2026. Filed Feb 25, 2026 (Schedule 13D/A).
- Stake
- 66.30%
- Shares
- 745,576,456
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 6 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Cambridge Equities, LP | 25.50% | 261,705,814 |
| MP 13 Ventures, LLC | 25.50% | 261,705,814 |
| NantWorks, LLC | 9.60% | 98,535,253 |
| Nant Capital, LLC | 30.30% | 339,465,529 |
| California Capital Equity, LLC | 10.40% | 106,511,412 |
| Patrick Soon-Shiong | 66.30% | 745,576,456 |
Source
Related
- Immunitybio, Inc.
- Patrick Soon-Shiong
- Immunitybio, Inc. shareholders
- Schedule 13D/A · Patrick Soon-Shiong · Nov 10, 2025
- Form 4 · Simon Barry J. · Oct 6, 2026
- Form 4 · Cohen Cheryl · Oct 6, 2026
- Schedule 13D/A · Cambridge Equities, LP · Aug 6, 2026
- Form 4 · Cohen Cheryl · Jul 6, 2026
- Form 4 · Selecky Christobel · Jul 6, 2026